Tema Oncology ETF (CANC) Dividend Yield, Date & History → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free CANC Stock Alerts $27.44 -0.18 (-0.65%) (As of 05/17/2024 ET) Add Compare Share Share DividendStock AnalysisChartDividendHoldingsRatingsSocial MediaStock AnalysisChartDividendHoldingsRatingsSocial Media Dividend SummaryDividend Yield0.51%Annual Dividend$0.14Recent Dividend Payment Dec. 15 Get Dividend Stock Ideas Daily Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news. Email Address Skip Charts & View Dividend HistoryCANC Dividend PaymentsOpen Tema Oncology ETF in Dividend Calculator →CANC Dividend Yield Over Time Open Tema Oncology ETF in Dividend Yield Calculator → Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Tema Oncology ETF vs. The CompetitionTypeTema Oncology ETF CompaniesNASDAQ CompaniesAnnual Dividend$0.14$1.08$1.24Dividend Yield0.51%1,470.63%390.79%Annualized 3-Year Dividend Growth0.00%3,361.00%1,378.66% Tema Oncology ETF Dividend History by QuarterAnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date12/12/2023Variable$0.149112/13/202312/14/202312/15/2023(Data available from 1/1/2013 forward) Tema Oncology ETF Dividend - Frequently Asked Questions What is Tema Oncology ETF's dividend yield? The current dividend yield for Tema Oncology ETF is 0.51%. Learn more on CANC's dividend yield history. How much is Tema Oncology ETF's annual dividend? The annual dividend for CANC shares is $0.14. Learn more on CANC's annual dividend history. How often does Tema Oncology ETF pay dividends? Tema Oncology ETF pays none dividends to shareholders. More Dividend Resources from MarketBeat Related Companies: NERD Dividend EQRR Dividend SPAQ Dividend GXTG Dividend EMIF Dividend TMET Dividend SETM Dividend FDIG Dividend BKWO Dividend BITS Dividend Dividend Tools: Dividend Stocks Overview Dividend Investing Guide Dividend Newsletter Dividend Screener Dividend Capture Stocks Dividend Calculator (Web) Dividend Calculator (Excel) Dividend Payout Ratio Calculator Dividend Tax Calculator Dividend Yield Calculator Ex-Dividend Calendar Dividend Announcements Dividend Increases Dividend Cuts Special Dividends Stock Lists: Best Dividend Stocks Blue Chip Stocks Cheap Dividend Stocks Dividend Achievers Dividend Aristocrats Dividend Challengers Dividend Champions Dividend Contenders Dividend ETFs Dividend Kings High-Yield REITs High-Yield Stocks Monthly Dividend Stocks Real Estate Investment Trusts Latest Articles: Alphabet Changes the Narrative with Its First-Ever Dividend3 High Dividend Stocks to Replace Lower Savings Yields Ahead3 Small Dividend Paying Banks Insiders are BuyingProfit pillars: 5 Dividend aristocrats for reliable incomeHigher VIX just made Realty Income’s 6% dividend better2 more high-quality dividend growers to buy on the dipCoca-Cola: Top-Rated dividend stock breaks out ahead of earningsBP stock looks bullish on high dividend yield, new CEO3 high-quality dividend growers to buy on the dip More Dividend News This page (NASDAQ:CANC) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media41 banks launch ‘crypto dollar’Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
